USPTO Patent Application: Dietary Compositions for Health and Diabetes Treatment

ChangeBridge: Patent Apps - Pharma (A61K)

Published December 2nd, 2025

Detected March 26th, 2026

Summary

The USPTO has published a patent application (US20260083739A1) for dietary compositions containing minerals and vitamins, intended for various health benefits including diabetes treatment, improved athletic performance, and immune support. The application was filed on December 2, 2025.

View original document View source feed page

What changed

This document is a USPTO patent application (US20260083739A1) for novel dietary compositions. The application details formulations of minerals and vitamins, potentially combined with marine omega-3 fatty acids or coenzyme Q10, aimed at providing health benefits. Specific applications mentioned include the treatment of prediabetes, type 1 and type 2 diabetes, improving athletic recovery and performance, enhancing immune response, and treating conditions like myalgic encephalomyelitis and Crohn's disease symptoms.

As this is a patent application, it does not impose immediate regulatory requirements or compliance deadlines on regulated entities. However, it signals potential future developments in the pharmaceutical and nutritional supplement sectors. Companies involved in these areas, particularly those developing diabetes treatments or performance-enhancing supplements, should monitor the progress of this patent application and related intellectual property.

Source document (simplified)

← USPTO Patent Applications

DIETARY MACRO/MICRONUTRITIONAL COMPOSITIONS AND APPLICATIONS THEREOF

Application US20260083739A1 Kind: A1 Mar 26, 2026

Inventors

Atif DABDOUB

Abstract

Provided herein are compositions composed of a plurality of minerals and vitamins that provide numerous health benefits and quality of life to subjects in need thereof. Also described herein are kits composed of the compositions described herein with a marine omega 3 fatty acid, coenzyme Q10, or a combination thereof. In one aspect, the compositions described herein can treat a subject diagnosed with prediabetes, type 1 diabetes, type 2 diabetes or insulin uptake. In another aspect, the compositions described herein can increase the performance of athletes by relaxing and dilating blood vessels, thus improve circulation as well as shorten the time of recovery after exercises or games. In another aspect, the compositions described herein can improve the well-being and immune response system. It also improves the human system against bacterial and fungal infections. In another aspect, the compositions described herein can treat myalgic encephalomyelitis in a subject. In another aspect, the compositions described herein can reduce or prevent one or more symptoms of Crohn's disease in a subject. In another aspect, the compositions described herein can enhance one or more physical properties of a subject after exercise.

CPC Classifications

A61K 31/51 A61K 31/122 A61K 31/197 A61K 31/198 A61K 31/201 A61K 31/205 A61K 31/375 A61K 31/381 A61K 31/4188 A61K 31/4415 A61K 31/455 A61K 31/519 A61K 31/525 A61K 31/593 A61K 31/714 A61K 31/732 A61K 33/04 A61K 33/06 A61K 33/22 A61K 33/24 A61K 33/26 A61K 33/30 A61K 36/21 A61K 38/063 A61K 47/36 A61K 47/46 A61P 3/02 A61P 39/06